HOME >> MEDICINE >> NEWS
Artery variations increase complication risk in liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... The Aresty Institute of ... finance programs to address the increasingly complex educational needs of today's global executives. ... of sophisticated corporate finance and will increase their ability to confidently take action ...
(Date:3/30/2017)... PA (PRWEB) , ... March 30, 2017 , ... An inventor and manicurist from Greet, ... in my profession I try to help customers maintain clean and healthy feet, so I ... take care of their feet at home, I designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN ...
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... ... 2017 , ... During the last week of March, Chad Kawa, MD of ... in the local community. , Colon cancer is the second leading cause of ... while it is small, confined and easier to treat. If you are 50 or ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to ... develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain ... on finding more effective treatment options, the San Diego Gamma Knife Center ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... , March 30, 2017 Stock-Callers.com navigates ... the research, development, and production of non-electronic medical, surgical, dental, ... Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: BDX), ... (NYSE: BCR ). Download the free research reports ... ...
(Date:3/30/2017)... -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... dose-ranging study of AKCEA-APO(a)-L Rx in patients with ... study is to determine the dose level and frequency ... Phase 3 cardiovascular outcome study. AKCEA-APO(a)-L ... Novartis to develop and commercialize drugs to treat patients ...
(Date:3/29/2017)... CITY , March 29, 2017  Bodycad ... and Drug Administration (FDA) 510(k) clearance for its ... of this truly personalized orthopaedic restoration. Bodycad is ... for a joint reconstruction implant system. ... to optimize personalized restoration of the patient,s unique ...
Breaking Medicine Technology:
Cached News: